Parathyroid disease and calcium metabolism

British Journal of Anaesthesia

Volumn 85, Issue 1, 2000, Pages 29-43

  Mihai, R ^a   Farndon, J R ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Hormones; Ions, calcium; Surgery

Indexed keywords

2 OXOGLUTARIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CATECHOLAMINE; CLODRONIC ACID; CYCLIN D1; DEFEROXAMINE; DIGITALIS; DOPAMINE; ETIDRONIC ACID; FUROSEMIDE; GLUCOCORTICOID; LOOP DIURETIC AGENT; MAGNESIUM; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; OCTREOTIDE; PAMIDRONIC ACID; PARATHYROID HORMONE; PROPRANOLOL DERIVATIVE; RETINOBLASTOMA PROTEIN; STEROID; VITAMIN D;

BONE DISEASE; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CARDIOTOXICITY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIET THERAPY; DRUG TOXICITY; ELECTROCARDIOGRAPHY MONITORING; EMBRYOLOGY; EXTRACELLULAR CALCIUM; FAMILIAL DISEASE; FLUID THERAPY; GASTROINTESTINAL DISEASE; HUMAN; HYPERCALCEMIA; HYPERTENSION; KIDNEY DISEASE; MULTIPLE ENDOCRINE NEOPLASIA; NERVE INJURY; NEUROFIBROMATOSIS; NEUROMUSCULAR DISEASE; NEUROPSYCHIATRY; PARATHYROID DISEASE; PRIMARY HYPERALDOSTERONISM; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; SIPPLE SYNDROME; TUMOR SUPPRESSOR GENE;

EID: 0034046147     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.1.29     Document Type: Article

References (106)

1. Albright F, Baird PC, Cope O et al. Studies of the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci 1934; 187: 49-65
2. Anast CS, Winnacker JL, Forte LR, Burns TW Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 1976; 42: 707-17
3. Arnold A, Staunton CE, Kim HG et al. Monoclonality and abnormal PTH genes in parathyroid adenomas. New Engl J Med 1988; 318: 658-62
4. Bassett JDH, Forbes SA, Pannett AAJ et al. Characterisation of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1988; 62: 232-44
5. Bates S, Peters G. Cyclin DI as a cellular proto-oncogene. Sem Cancer Biol 1995; 6: 73-82
6. Bauer W, Federman DD. Hyperparathyroidism epitomized: the case of Captain Charles E. Martell. Metabolism 1962; 11: 21-9
7. Bilezikian JP. Management of hypercalcaemia. J Clin Endocrinol Metab 1993; 77: 1445-9
8. Boucher A, D'Amour P, Hamel L et al. Estrogen replacement decreases the set point of parathyroid hormone stimulation of calcium in normal postmenopausal women. J Clin Endocrinol Metob 1989; 68: 831-6
9. Brown EM. Four parameter model of the sigmoidal relationship between PTH release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983; 56: 572-81
10. 2+ and other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411
11. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-80.
12. Brown EM, Segre GV, Goldring SR. Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium. Ballière's Clin Endocrinol Metab 1996; 10: 123-61
13. Carling T, Kindmark A, Hellman P et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Med 1995; 1: 1309-11
14. Chandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997; 276: 404-8
15. Clark O, Siperstein A. Hypercalcaemic syndrome: hyperparathyroidism. In: Freisen S, Thompson N, eds. Surgical Endocrinology - Clinical Syndromes, 2nd edn. Philadelphia: J. B. Lippincott, 1990; 311-12
16. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ. Treatment of hypercalcaemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 1998; 83: 1083-8
17. Collip JB. The extraction of a parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium. J Biol Chem 1925; 63: 395-438
18. Cryns VL, Rubio MP, Thor AD et al. p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 1320-24
19. Cryns VL, Thor A, Xu HJ et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. New Engl J Med 1994; 330: 757-61
20. Demeure M, McGee D, Wilkes W et al. Results of surgical treatment for hyperparathyroidism associated with renal disease. Am J Surg 1990; 160: 337-40
21. Elvius M, Lagrelius A, Nygren A, Alveryd A, Christensson TAT, Nordenstrom J. Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur J Surg Acta Chirurg 1995; 161: 863-9
22. The European Consortium on MENI. Identification of the multiple endocrine neoplasia type 1 (MENI) gene. Hum Mol Genet 1997; 6: 1117-83
23. Falchetti A, Bale A, Amorosi A. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993; 76: 139-44
24. Farndon JR, Geraghty JM, Dilley WG, Handwerger S, Leight GS. Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism. World J Surg 1987; 11: 252-7
25. Farndon JR, Routledge PA et al. Beta-adrenergic effects on PTH release. Br J Surg 1981; 68: 77-83
26. Fine A, Fleming S, Leslie W. Calciphylaxis presenting with calf pain and plaques in four continuous ambulatory peritoneal dialysis patients and in one predialysis patient. Am J Kidney Dis 1995; 25: 498-502
27. Fitzpatrick LA, Bilezikian JP. Acute primary hyperparathyroidism. Am J Med 1987; 82: 275-82
28. Friedman E, Sakaguci K, Bale AE et al. Clonality of parathyroid tumours in familial MEN type 1. New Engl J Med 1989; 321: 213-18
29. Friedman E, Bale AE, Marx SJ et al. Genetic abnormalities in parathyroid adenomas. J Clin Endocrinol Metab 1990; 71: 293-7
30. Garrett JE, Capuano IV, Hammerland LG et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs J Biol Chem 1995; 270: 12919-25
31. Garrett JE, Steffey ME, Nemeth EF. The calcium receptor agonist R-568 suppresses PTH mRNA levels in cultured bovine parathyroid cells. J Bone Min Res 1995; 10: S387 (M539)
32. Gilmour JR The normal histology of the parathyroid glands. Pathol Bocteriol 1937; 45: 507-22 and 48: 187-222
33. Gilmour JR The normal histology of the parathyroid glands. Pathol Bocteriol 1937; 45: 507-22 and 48: 187-222
34. Goodman WG, Belin T, Gales B, Juppner H, Segre GV, Salusky IB. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney Int 1995; 48: 1553-8
35. Grant CS, Weaver A. Treatment of primary parathyroid hyperplasia: representative experience at Mayo Clinic. Acta Chirurg Austr 1994; 26 (Suppl 112): 41-4
36. Gray's Anatomy (Bannister LH, Berry MM, Collins P et al. eds). New York: Churchill Livingstone, 1995; 17
37. Hakim JP, Levine MA. Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 1994; 78: 103-6
38. 2+ receptor expressed in Xenopus loevis oocytes by NPS-467 R NPS-568. Mol Pharmacol 1998; 53: 1083-8
39. Hanson AM. Parathyroid preparations. Milit Surg 1923; 53: 554-60, 701-18
40. Harms HM, Schlinke E, Neubauer O. Pulse amplitude and frequency modulation of parathyroid hormone in primary hyperparathyroidism. J Clin Endocrinol Metab 1994; 78: 53-7
41. Hasse C, Zielke A, Bruns C et al. Influence of somatostatin to biochemical parameters in patients with primary hyperparathyroidism. Exp Clin Endocrinol Diab 1995; 103: 391-7
42. Hedback G, Oden A, Tissel LA. Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery 1995; 117: 134-9
43. Heinrich G, Kronenberg HM, Potts JT, Habener JF. Gene encoding parathyroid hormone - nucleotide sequence of the rat gene and deduced amino acid sequence of rat preproparathyroid hormone. J Biol Chem 1984; 259: 3320-29
44. Hewin DF, Brammar TJ, Kabala J, Farndon JR. Role of preoperative localization in the management of primary hyperparathyroidism. Br J Surg 1997; 84: 1377-80
45. 2+-binding receptor with potential intracellular signalling properties. Eur J Biochem 1996; 239: 132-7
46. Ho C, Conner D, Pollak M et al. A mouse model of human familial hypercalcaemia and neonatal severe hyperparathyroidism. Nature Genet 1995; 11: 389-94
47. Hosokawa Y, Pollak MR, Brown EM et al. The extracellular calcium-sensing receptor gene in human parathyroid tumours. J Clin Endocrinol Metab 1995; 80: 3107-10
48. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred and eighty-six cases of parathyroid carcinoma treated in the US between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer, 86: 538-44
49. Joborn C, Ljunghall S, Larssan K et al. Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement. Clin Endocrinol 1991; 34: 335-9
50. Juhlin C, Klareskog L, Nygren P et al. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 1988; 122: 2999-3001
51. Kassem M, Zhang X, Brask S et al. Familial isolated primary hyperparathyroidism. Clin Endocrinol 1994; 41: 415-20
52. 3H]-1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with chronic renal failure. New Engl J Med 1987; 316: 1573-7
53. Larsson C, Skogseid K, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85-7
54. LeDouarin N. The Neural Crest. Cambridge: Cambridge University Press, 1984.
55. Lind L, Ljunghall S. Parathyroid hormone and blood pressure - is there a relationship? Nephrol Dial Transplant 1995; 10: 450-51
56. Lind L, Ljunghall S. Pre-operative evaluation of risk factors for complications in patients with primary hyperparathyroidism. Eur J Clin Invest 1995; 25: 955-8
57. Llach F. Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited. Am J Kidney Dis 1995; 25: 663-79
58. Llach F, Felsenfeld A, Coleman M et of. Renal osteodistrophy in 131 unselected hemodialysis patients. Kidney Int 1984; 25: 187
59. Lucarotti ME, Hamilton JA, Farndon JR. Somatostatin and primary hyperparathyroidism. Br J Surg 1994; 81: 1141-3
60. Lundgren S, Hjalm G, Hellman P et al. A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belongs to the LDL-receptor protein superfamily. Exp Cell Res 1994; 212: 344-50
61. Mandl F. Therapeutischer Versuch bein einem Fall von Ostitis fibrosa generalisata mittles. Exstirpation eines Epithelkorperchentumors. Wien Klin Wochenschr Zentral 1926; 53: 260-64
62. Mansberger AR Jr, Wei JP. Surgical embryology and anatomy of the thyroid and parathyroid glands. Surg Clin N Am 1993; 73: 727-46
63. Mihai R, Farndon JR. Familial endocrine disease - genetics and early treatment. In: Farndon JR. ed. A Companion to Specialist Surgical Practice: Breast and Endocrine Surgery. London: W. B. Saunders, 1997: 113-42
64. Mihai R, Lai T, Schofiekl G, Farndon JR. Thimerosal increases the responsiveness of the calcium receptor in human parathyroid and rMTC6-23 cells. Cell Calcium 1999; 26: 95-102
65. Monchik JM. Presidential address: Normocalcemic hyperparathyroidism. Surgery 1995; 118: 917-23
66. Motokura T, Bloom T, Kim HG et al. A novel cyclin encoded by a bcll-linked candidate oncogene. Nature 1991; 350: 512-15
67. Mulligan LM, Marsh DJ, Robinson BG et al. Genotype-phenotype correlation in MEN2: report of the International RET Mutations Consortium. J Intern Med 1995; 238: 343-6
68. Neonakis E, Wheeler MH, Krishnan H, Coles GA, Davies F, Woodhead JS. Results of surgical treatment of renal hyperparathyroidism. Arch Surg 1995; 130: 643-8
69. Nichols P, Owen JP, Ellis HA et al. Parathyroidectomy in chronic renal failure: a nine year follow up study. Q J Med 1990; 77: 1175-93
70. Owen R. On the anatomy of the Indian rhinoceros (Rh. unicornis). Trans Zool Soc Lond 1862; 4: 31-58
71. Pasini B, Ceccherini I, Romeo G. RET muations in human disease. Trends Genet 1996; 12: 138-44
72. Pausova Z, Soliman E, Amizuka N et al. Expression of the RET protooncogene in hyperparathyroid tissue: implications in the pathogenesis of the parathyroid disease. J Bone Min Res 1995; 10: 249
73. Pearce SHS, Bai M, Quinn SJ, Kifor O, Brown EM, Thakker RV. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 1996; 98: 1860-66
74. Pearse AGE. Genesis of neuroendocrine system. In: Friesen SR, Thompson NW, eds. Surgical Endocrinology - Clinical Syndromes, 2nd edn. Philadelphia: J. B. Lippincott, 1990: 15-21
75. Potts JT, Bringhurst FR, Gardella T et al. Parathyroid hormone: physiology, chemistry, biosynthesis, secretion, metabolism and mode of action. In: De Groot Textbook of Endocrinology, 1995: 920-66
76. Punch JD, Thompson NW, Merion RM et al. Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients: A 25-year single-center experience. Arch Surg 1995; 130: 538-43
77. Riccardi D, Park J, Lee WS et al. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 1995; 92: 131-5
78. Rodan GA, Fleish HA. Bisphosphonates: mechanism of action. J Clin Invest 1996; 97: 2692-6
79. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM et al. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991; 6: 449-53
80. Rothmund M, Wagner P, Schark C. Subtotal parathyroidectomy vs. total parathyroidectomy and autotransplantation in secondary hyperparathyroidism - a randomised trial. World J Surg 1991; 15: 745-50
81. Russell J, Bar A, Sherwood LM, Hurwitz S. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology 1993; 132: 2639-44
82. Samuels MH, Veldhuis JD, Cawley C et al. Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis. J Clin Endocrinol Metab 1993; 77: 339-403
83. Sandstrom I. Om en ny kortel hos menniskan och atskilliga daggdjur. Uppsala Lakaref Forhande 1880; 15: 441-71
84. Schmitt CP, Schaefer F, Bruch A et al. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. J Clin Endocrinol Metab 1996; 81: 4236-43
85. Schneider H, Feyen JH, Seuwen K, Mowa NR. Cloning and functional expression of a human parathyroid hormone receptor. Eur J Pharmacol 1993; 246: 149-55
86. Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E, Lubin J. Dose-response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab 1995; 80: 254-7
87. Scholz DA, Purnell DC. Asymptomatic primary hyperparathyroidism. 10-year prospective study. Mayo Clin Proc 1981; 56: 473-8
88. Silverberg SJ, Bone in HG, Marriott TB et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. New Engl J Med 1997; 337: 1506-10
89. Stevenson JC, Lynn JA. Time to end a conservative treatment for mild hyperparathyroidism. Br Med J 1988; 296: 1016-17
90. Sugimoto T, Brown AJ, Ritter C et al. Combined effects of dexamethasone and 1,25 dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Endocrinology 1989; 125: 638-641
91. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996; 56: 599-605
92. Thakker RV, Bouloux P, Wooding C et al. Association of parathyroid tumours in MEN type 1 with loss of alleles on chromosome 11. New Engl J Med 1989; 321: 218-24.
93. Thompson NW, Sandelin K. Primary hyperparathyroidism caused by multiple gland disease (hyperplasia) long-term results in familial and sporadic cases. Acta Chirurg Austr 1994; 26 (Suppl 112): 44-7
94. Thomson DB, Samowitz WS, Odelberg S et al. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 1995; 80: 3377-80
95. Timio M. Cardiotoxicity of parathyroid hormone in chronic renal failure, Ital J Min Electrolyte Metab 1995; 9: 119-24
96. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 1995; 44 (Suppl 1): 542-7
97. Tommasi M, Brocchi A, Benucci A et al. Intraoperative fall in plasma levels of intact parathyroid hormone in patients undergoing parathyroid adenomectomy. Int J Biol Markers 1995; 10: 206-10
98. Trydal T, Varhaug JE, Myking A et al. Serum vitamin D metabolites and calcitriol receptor concentration in parathyroid tissue in primary hyperparathyroidism. Acta Endocrinol 1992; 127: 407-12
99. Vetto JT, Brennan MF, Woodruf J, Burt M. Parathyroid carcinoma: diagnosis and clinical history. Surgery 1993; 114: 882-92
100. Weaver CA, Gordon DF, Kissil MS, Mead DA, Kemper B. Isolation and complete nucleotide sequence of the gene for bovine parathyroid hormone. Gene 1984; 28: 319-29
101. Weber CJ, Marangos PJ, Richardson S et al. Presence of neuron-specific enolase and somatostatin in human parathyroid tissues Surgery 1985; 98: 1008-12
102. Wei JP, Burke GJ. Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scan. Am J Surg 1995; 170: 488-91
103. Wong WK, Wong NA, Farndon JR. Early postoperative plasma calcium concentration as a predictor of the need for calcium supplement after parathyroidectomy. Br J Surg 1996; 83: 532-4
104. Zabel M, Surdyk J, Biela-Jacek I. Immunohistochemical study of the distribution of S-100 protein in the parathyroid glands of rats and guinea pigs. Histochemistry 1986; 86: 97-9
105. Zimmermann E, Wassmer S, Steudle V. Long-term treatment with calcium-alpha-ketoglutarate corrects secondary hyperparathyroidism. Min Electrolyte Metab 1996; 22: 196-9
106. Zmora O, Schachter PP, Heyman Z et al. Correct preoperative localization: Does it permit a change in operative strategy for primary hyperparathyroidism? Surgery 1995; 118: 932-5